Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Welcome to AllianceRx Walgreens Pharmacy

(PRNewsfoto/AllianceRx Walgreens Pharmacy)

News provided by

AllianceRx Walgreens Pharmacy

Jun 24, 2022, 08:02 ET

Share this article

Share toX

Share this article

Share toX

One of the nation's largest specialty and home delivery pharmacies has new look and name, pledges same commitment to patient care.

ORLANDO, Fla., June 24, 2022 /PRNewswire/ -- One of the country's largest specialty and home delivery pharmacies is now AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of the company in January, necessitating the name change.

"AllianceRx Walgreens Pharmacy is the same specialty and home delivery pharmacy our patients have come to trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We continue putting patients first in everything we do to provide hope and care for better tomorrows."

New name comes with some changes
In addition to the new name, patients and partners may notice a few other changes at AllianceRx Walgreens Pharmacy:

  • A more personalized pharmacy experience: AllianceRx Walgreens Pharmacy's Specialty360 therapy teams will provide patients with personalized care throughout their healthcare journey. New dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members – including pharmacists, pharmacy technicians, nurses and dietitians – will be certified in specific diagnoses along with associated therapies. Those diagnoses include conditions related to behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.

    "As the pharmacy industry has evolved, the needs of our patients have become more complex. To better serve them, we transformed our operating model to create dedicated teams that focus on specific conditions and therapies," says Tracey James, RPh, chief operating officer. "We've always prided ourselves on providing comprehensive patient care across functional teams. We're confident the changes we've made will not only improve patient outcomes but will also reduce the cost of care and enhance the patient and provider experience."

  • Greater access to hard-to-find medications: AllianceRx Walgreens Pharmacy has gained access to more than 20 limited distribution drugs (LDDs) since September 2021. "This also included some new launches or additions to previously excluded products," James says. "And, we have six more LDDs in the pipeline, which if we win, will lead to our best year on record."

    James attributes the company's leading access to hard-to-find medications to its commitment to patient care. "First, manufacturers know we have dedicated teams working closely with patients to help make sure they stay on therapy. And second, they want a partner who is experienced in handling high-touch medications," she says. "They know they have that in AllianceRx Walgreens Pharmacy. We share the same goal of improving patient outcomes while helping reduce healthcare costs."

  • Helping make specialty medications affordable: Specialty drugs typically require special handling, administration or monitoring, which is why they cost more than regular medications. Just five years ago, specialty medications accounted for approximately 38% of total drug expenditures.1 Today, specialty medications account for 50% or greater of the total prescription spend. In some cases, employers are seeing specialty costs account for 60% or even greater of their total drug spending.2

    Wright says AllianceRx Walgreens Pharmacy has reimbursement specialists who assist with prior authorizations and questions about insurance coverage. "They also help identify financial assistance programs available to eligible patients. In fact, we connected eligible patients to more than $600 million in financial assistance between 2019 and 2021,"3 he says. "We have always worked to provide this level of attention and support to our patients every day, and this is something we will continue at AllianceRx Walgreens Pharmacy."

  • Diversity, equity and inclusion (DE&I) achievements: A greater focus on DE&I has led to the creation of a company DE&I council as well as new team member resource groups focusing on how to bring different groups of people together across the organization to celebrate, recognize and acknowledge one another.

  • A new headquarters: "Over the last several years, we've focused on reducing our physical footprint as part of our long-term real estate strategy," Wright says. The company has ceased dispensing of specialty prescriptions from Orlando and has relocated its headquarters to the nearby Walgreens regional office. Wright says this was a natural shift as many of the company's team members successfully work remotely.

Looking Toward the Future of Specialty Pharmacy
Wright finds specialty pharmacy to be an exciting space and predicts an industry focus on improving the patient journey, including how specialty pharmacies engage digitally with patients and providers.

  • Eliminating social barriers: Social determinants of health are everyday factors that can prevent patients from staying on therapy. These may include housing instability, food insecurity or not being able to get to your doctor's appointment. "If we can help identify and address these barriers, then our patients will be able to stay on treatment and have better outcomes," James says.
  • Data-focused care: Wright predicts pharmacists are going to play a more active role in the collection of patient-reported outcomes and the use of real-world evidence. "Both of these are instrumental in helping to individualize care, which helps patients feel heard and understood and is vital in the patient journey," he says.

"As we focus on the future, we have evolved our company greatly in the last several months," Wright says. "These changes give us a great opportunity to look at things through new eyes, to face new challenges, to consider new competitors and to reposition ourselves in the market. We are excited about the future of specialty pharmacy and AllianceRx Walgreens Pharmacy's role in shaping it."

About AllianceRx Walgreens Pharmacy
AllianceRx Walgreens Pharmacy (AllianceRxWP.com) provides hope and care for better tomorrows to patients with rare diseases and chronic conditions by delivering medications from its specialty and home delivery pharmacies. Our advanced analytical capabilities, pharmacy expertise and technology solutions enable providers, pharmaceutical manufacturers and health plans to deliver optimal health outcomes. Through personalized care and clinical programs, along with access to the leading number of limited distribution drugs, patients can get back to what matters most. Headquartered in Orlando, Florida, the company holds several national pharmacy accreditations and has team members across the United States.

1 https://www.admere.com/amr-blog/the-rising-costs-of-specialty-drugs
2 https://www.forbes.com/sites/brucejapsen/2022/05/03/health-plans-brace-for-specialty-drugs-eclipsing-50-of-prescription-spending/?sh=4c27be58307d
3 https://www.alliancerxwp.com/contents/press-releases/alliancerx-walgreens-prime-conne.html

Media Contact
Adrienne Foley, APR
External communications manager
[email protected]

SOURCE AllianceRx Walgreens Pharmacy

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.